Patents by Inventor Kieran James Crowley

Kieran James Crowley has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10953003
    Abstract: The present invention relates to methods of treating patients with advanced forms of cancer, such as clear cell renal cell carcinoma, in which X4P-001 is administered in order to reduce angiogenic escape that typically occurs with TKI therapy. The methods demonstrate surprising results, including regression of tumor size and cell number, with comparatively little toxicity.
    Type: Grant
    Filed: December 14, 2016
    Date of Patent: March 23, 2021
    Assignees: X4 PHARMACEUTICALS, INC., GENZYME CORP.
    Inventors: Paula Marie Ragan, Robert D. Arbeit, Kieran James Crowley
  • Publication number: 20180369229
    Abstract: The present invention relates to methods of treating patients with advanced forms of cancer, such as clear cell renal cell carcinoma, in which X4P-001 is administered in order to reduce angiogenic escape that typically occurs with TKI therapy. The methods demonstrate surprising results, including regression of tumor size and cell number, with comparatively little toxicity.
    Type: Application
    Filed: December 14, 2016
    Publication date: December 27, 2018
    Applicants: X4 Pharmaceuticals, Inc., Genzyme Corp.
    Inventors: Paula Marie Ragan, Robert D. Arbeit, Kieran James Crowley
  • Patent number: 9775819
    Abstract: An oral solid dosage form containing nanoparticles is made by (a) reducing the particle size of at least one pharmaceutically active ingredient dispersed in a solution containing fish gelatin to form a nanosuspension and (b) freeze-drying the nanosuspension of step (a) to form the oral solid dosage form.
    Type: Grant
    Filed: September 16, 2009
    Date of Patent: October 3, 2017
    Assignee: R.P. SCHERER TECHNOLOGIES, LLC
    Inventors: Deepak Bahl, Kieran James Crowley, Danny Yu
  • Publication number: 20110064812
    Abstract: An oral solid dosage form containing nanoparticles is made by (a) reducing the particle size of at least one pharmaceutically active ingredient dispersed in a solution containing fish gelatin to form a nanosuspension and (b) freeze-drying the nanosuspension of step (a) to form the oral solid dosage form.
    Type: Application
    Filed: September 16, 2009
    Publication date: March 17, 2011
    Inventors: Deepak Bahl, Kieran James Crowley, Danny Yu